Abstract Aims Renin–angiotensin–aldosterone system inhibitors (RAASi) are foundational in the management of heart failure (HF) and chronic kidney disease (CKD) but increase the risk of hyperkalaemia. To facilitate continuation of RAASi therapy, guidelines suggest managing hyperkalaemia using newer potassium binders such as sodium zirconium ...
Charles V. Pollack Jr.+9 more
wiley +1 more source
Qualitative analysis of cardiovascular disease prevention in dental practice. [PDF]
O'Farrell Á+3 more
europepmc +1 more source
Abstract Aims The last released European guidelines on the management of heart failure (HF) recommend in patients with chronic HF with reduced ejection fraction (HFrEF) a pharmacological approach based on four fundamental drugs to be rapidly implemented and then uptitrated to modify disease progression.
Stefania Paolillo+62 more
wiley +1 more source
Publisher Correction: Characteristics of transition to turbulence in a healthy thoracic aorta using large eddy simulation. [PDF]
Cheng K, Akhtar S, Lee KY, Lee SW.
europepmc +1 more source
Experiences of Lesbian, Gay, Bisexual, Transgender, and Queer Cardiology Physicians and Fellows in Training. [PDF]
Cook SC+8 more
europepmc +1 more source
Effect of Renal Impairment on Clinical Outcomes After Mitral Valve Transcatheter Edge-to-Edge Repair. [PDF]
Tanaka K+30 more
europepmc +1 more source
Delivering guideline-directed medical therapy for heart failure with reduced ejection fraction as an over-encapsulated polypill: rationale and protocol for the COMBO-HF-X pilot crossover randomised clinical trial. [PDF]
DeJong C+17 more
europepmc +1 more source
When Psychiatry Meets Cardiology: A Case Report on the Challenges of Diagnosing and Managing Cardiovascular Disease in Patients With Severe Mental Illness. [PDF]
Edhem L+5 more
europepmc +1 more source